(617) 206-1055

Official logo of Stem Cell Therapy Experts featuring clean, clinical design with holistic symbolism

Stem Cells for IBD: Tackling Root Causes, Not Symptoms

Inflammatory Bowel Disease Treatment with Stem Cells: A Holistic, Root-Cause Approach

Conditions We Treat

  • Osteoarthritis

  • Rheumatoid Arthritis

  • Psoriatic Arthritis

  • Neuropathy

  • Chronic Pain

  • Long COVID

  • Multiple Sclerosis

  • COPD

  • Autoimmune Conditions

These are just a few of the conditions we address with regenerative therapy.

See the Full List of Conditions We Treat

Conditions Treated

Beyond the Gut: Understanding IBD as a Whole-Body Condition

Traditional medicine often frames IBD as a gastrointestinal disorder. But emerging research and clinical observations reveal a broader picture. According to Dr. Yi Song, “Inflammatory bowel disease is not just a digestive system problem. It has an autoimmune component and is also related to the nervous system acting on the digestive system.” Patients with IBD often experience:
  • Cyclical inflammation and unpredictable flare-ups
  • Systemic symptoms like fatigue, joint pain, or brain fog
  • Digestive issues ranging from diarrhea and constipation to acid reflux
Many turn to strict elimination diets or immunosuppressive drugs. Yet, for a significant number of patients, these strategies bring only partial relief — and sometimes, none at all.
Diagram showing the brain, digestive tract, and immune system connected by arrows, illustrating how nervous system signals, gut health, and immune responses interact in inflammatory bowel disease.

Stem Cell Therapy: Targeting the Root Causes of IBD

SCTE’s stem cell protocol for IBD focuses on two key pillars: reducing systemic inflammation and regulating immune responses. Our treatments use high-viability, lab-expanded umbilical cord mesenchymal stem cells (MSCs), known for their regenerative and immunomodulatory capabilities.
  • Immune Modulation: MSCs help recalibrate the immune system, reducing the autoimmune attacks that drive intestinal inflammation.
  • Inflammation Reduction: By dampening inflammatory signaling throughout the body, stem cells reduce both gut-related and systemic symptoms.
  • Neuroregulation: Stem cells support balance between the brain-gut axis to alleviate nervous system-related triggers.
“The stem cell treatment for the inflammatory bowel condition is treating the whole body and treating the root cause, instead of just treating the symptoms.” — Dr. Yi Song

The SCTE Difference: Fresh, High-Potency Stem Cells

Unlike many U.S. clinics using frozen, off-the-shelf cells, SCTE provides fresh, lab-expanded stem cells with over 85–94% viability at the time of application. This ensures more active, functional cells reach the targeted tissues. Treatments are personalized based on each patient’s history, immune profile, and symptom patterns. Our Colombia-based clinical site allows us to treat complex immune-related conditions like IBD without the regulatory limitations present in the U.S.

Clinical Insight: Whole-System Impact for Long-Term Relief

At SCTE, we’ve seen patients with persistent digestive symptoms gain lasting relief, not through symptom suppression, but by addressing the body’s underlying imbalance. Treatments often lead to:
  • Reduced bowel urgency and fewer flare-ups
  • Improved energy and digestion
  • Decreased need for corticosteroids or immune-suppressing medications
This systems-level healing is rooted in a combination of advanced regenerative therapy and traditional principles that view the body as a network — not isolated parts.

Clinical Evidence Supporting Stem Cell Use for IBD

The scientific support for using mesenchymal stem cells (MSCs) in Inflammatory Bowel Disease (IBD) is steadily growing. Peer-reviewed clinical studies have shown that MSCs—especially those derived from umbilical cord tissue—can significantly reduce inflammation, support intestinal repair, and help achieve remission in patients with moderate to severe IBD.
  • Stem Cells Address Root Mechanisms in IBD, which includes Crohn’s disease and ulcerative colitis, is marked by chronic, dysregulated inflammation of the gastrointestinal tract. MSCs have been shown to home in on areas of inflammation, reduce immune overactivity, and promote healing of damaged mucosa through the secretion of bioactive molecules like interleukin-10 (IL-10), prostaglandin E2 (PGE2), and transforming growth factor beta (TGF-β).
  • Perianal fistulas are among the most difficult complications of Crohn’s disease. In the ADMIRE-CD clinical trial, patients receiving MSC-based therapy (Darvadstrocel) achieved significantly higher fistula closure rates than those on placebo. These results led to regulatory approvals in Europe and Japan for this type of stem cell therapy.
  • Early Findings in Ulcerative Colitis – Pilot studies in patients with active ulcerative colitis show that MSCs may reduce endoscopic disease severity and improve mucosal integrity. Although more large-scale trials are underway, early results suggest a promising therapeutic direction.

Is Stem Cell Therapy Right for Your IBD?

If you’ve struggled with IBD flare-ups despite conventional care, stem cell therapy may provide the systemic balance your body needs to heal. SCTE’s approach blends scientific rigor with holistic insight to offer treatment tailored to you — not just your diagnosis.

Scientific References

Talk to One Of Our Stem Cell Experts

Facing IBD flare-ups? Meet with our clinical team to review your symptoms, immune profile, and create a personalized stem cell plan—rooted in science and whole-body healing.

GET STARTED